1-o-hexadecyl-2-n-methylcarbamol -sn-glycerol-3-phosphocholine profile

The term 1-o-hexadecyl-2-n-methylcarbamol -sn-glycerol-3-phosphocholine is not a standard chemical name and it's likely there's a typo or misunderstanding in the name.

However, let's break down the components and see if we can find a similar compound that might be relevant:

* **1-o-hexadecyl:** This refers to a 16-carbon chain (hexadecyl) attached to the first carbon of glycerol.
* **-sn-glycerol-3-phosphocholine:** This is a common component of phospholipids, the building blocks of cell membranes. It indicates a glycerol backbone with a phosphate group (3-phosphocholine) attached to the third carbon of glycerol.
* **2-n-methylcarbamol:** This part is unclear and likely the source of the issue. Carbamol could be a typo for carbamoyl, which would indicate a carbamoyl group attached to the second carbon of glycerol.

**Possible Compounds:**

Based on the information above, the compound might be related to one of the following:

* **Lysophosphatidylcholine (LPC):** LPC is a type of phospholipid with a single fatty acid chain attached to the glycerol backbone. It's a natural component of cell membranes and plays a role in signaling and lipid metabolism.
* **Phosphatidylcholine (PC):** PC is a common phospholipid with two fatty acid chains attached to the glycerol backbone. It's the most abundant phospholipid in cell membranes and plays a crucial role in membrane structure and function.

**Why are these compounds important for research?**

* **Cell Membrane Research:** Phospholipids like LPC and PC are essential components of cell membranes, playing crucial roles in cell signaling, transport, and membrane integrity. Researchers study them to understand the structure and function of cell membranes and how they contribute to various cellular processes.
* **Lipid Metabolism:** LPC and PC are involved in lipid metabolism, the breakdown and synthesis of fats. Studying their role in this process can be crucial for understanding diseases like atherosclerosis and obesity.
* **Drug Development:** The structures of phospholipids can be modified to create new drugs with targeted effects on cell membranes or lipid metabolism.

**To clarify what you are looking for:**

It's important to verify the correct name and structure of the compound you're interested in. Double-check the source of the information or provide more context about the specific research area.

1-O-hexadecyl-2-N-methylcarbamol -sn-glycerol-3-phosphocholine: PAF analog found in rabbit cornea; induces collagenase expression in corneal epithelial cells [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

ID Source	ID
PubMed CID	124663
CHEMBL ID	1599651
SCHEMBL ID	5501409
MeSH ID	M0221642

Synonym
L120 ,
[(2r)-3-hexadecoxy-2-(methylcarbamoyloxy)propyl] 2-trimethylazaniumylethyl phosphate
mc-paf
methylcarbamyl paf
methyl-carbamyl platelet-activating factor
gtpl3427
NCGC00161384-01
NCGC00161384-02
NCGC00161384-03
HMS1989A04
methylcarbamol
c-paf
BML3-F03
[(2r)-3-hexadecoxy-2-(methylcarbamoyloxy)propyl] 2-(trimethylazaniumyl)ethyl phosphate
HMS1361A04
HMS1791A04
91575-58-5
4,7,9-trioxo-2-aza-8-phosphaundecan-11-aminium, 5-((hexadecyloxy)methyl)-8-hydroxy-n,n,n-trimethyl-3-oxo-, hydroxide, inner salt, 8-oxide, (r)-
5-((hexadecyloxy)methyl)-8-hydroxy-n,n,n-trimethyl-3-oxo-4,7,9-trioxo-2-aza-8-phosphaundecan-11-aminium hydroxide, inner salt, 8-oxide, (r)-
1-o-hexadecyl-2-n-methylcarbamol -sn-glycerol-3-phosphocholine
cpaf
mcplatelet activating factor
c-paf (carbamyl-paf )
SCHEMBL5501409
CHEMBL1599651
1-o-hexadecyl-2-n-methylcarbamyl-sn-glycero-3-phosphocholine
1-o-hexadecyl-2-o-(n-methylcarbamoyl)-sn-glyceryl-3-phosphorylcholine
methylcarbamyl paf c-16
HMS3402A04
HMS3648P12
AKOS027379118
1-o-palmitol-2-(n-methylcarbamyl)-sn-glycero-3-phospho-choline
Q27085367
(r)-3-(hexadecyloxy)-2-(methylcarbamoyloxy)propyl 2-(trimethylammonio)ethyl phosphate

Protein	Taxonomy	Measurement	Average (µ)	Min (ref.)	Avg (ref.)	Max (ref.)	Bioassay(s)
Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE	Homo sapiens (human)	Potency	4.4668	0.0032	45.4673	12,589.2998	AID2517
Chain A, Cruzipain	Trypanosoma cruzi	Potency	31.6228	0.0020	14.6779	39.8107	AID1476
TDP1 protein	Homo sapiens (human)	Potency	2.6493	0.0008	11.3822	44.6684	AID686978; AID686979
regulator of G-protein signaling 4	Homo sapiens (human)	Potency	0.2993	0.5318	15.4358	37.6858	AID504845
histone acetyltransferase KAT2A isoform 1	Homo sapiens (human)	Potency	2.8184	0.2512	15.8432	39.8107	AID504327
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Assay ID	Title	Year	Journal	Article
AID1347154	Primary screen GU AMC qHTS for Zika virus inhibitors	2020	Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49	Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1508630	Primary qHTS for small molecule stabilizers of the endoplasmic reticulum resident proteome: Secreted ER Calcium Modulated Protein (SERCaMP) assay	2021	Cell reports, 04-27, Volume: 35, Issue:4	A target-agnostic screen identifies approved drugs to stabilize the endoplasmic reticulum-resident proteome.
AID588519	A screen for compounds that inhibit viral RNA polymerase binding and polymerization activities	2011	Antiviral research, Sep, Volume: 91, Issue:3	High-throughput screening identification of poliovirus RNA-dependent RNA polymerase inhibitors.
AID540299	A screen for compounds that inhibit the MenB enzyme of Mycobacterium tuberculosis	2010	Bioorganic & medicinal chemistry letters, Nov-01, Volume: 20, Issue:21	Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Timeframe	Studies, This Drug (%)	All Drugs %
pre-1990	0 (0.00)	18.7374
1990's	7 (31.82)	18.2507
2000's	6 (27.27)	29.6817
2010's	7 (31.82)	24.3611
2020's	2 (9.09)	2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Publication Type	This drug (%)	All Drugs (%)
Trials	0 (0.00%)	5.53%
Reviews	0 (0.00%)	6.00%
Case Studies	0 (0.00%)	4.05%
Observational	0 (0.00%)	0.25%
Other	22 (100.00%)	84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Substance	Relationship Strength	Studies	Classes	Roles
edelfosine edelfosine: RN given refers to parent cpd. edelfosine : A racemate comprising equimolar amounts of (R)- and (S)-edelfosine.. 1-octadecyl-2-methylglycero-3-phosphocholine : A glycerophosphocholine that is glycero-3-phosphocholine substituted at positions 1 and 2 by octadecyl and methyl groups respectively.	2.39	2	glycerophosphocholine
benzyl isothiocyanate benzyl isothiocyanate: inhibits carcinogen-induced neoplasia; structure in Negwer, 5th ed, #715; also promotes urinary bladder carcinoma	2.11	1	benzenes; isothiocyanate	antibacterial drug
cycloheximide Cycloheximide: Antibiotic substance isolated from streptomycin-producing strains of Streptomyces griseus. It acts by inhibiting elongation during protein synthesis.. cycloheximide : A dicarboximide that is 4-(2-hydroxyethyl)piperidine-2,6-dione in which one of the hydrogens attached to the carbon bearing the hydroxy group is replaced by a 3,5-dimethyl-2-oxocyclohexyl group. It is an antibiotic produced by the bacterium Streptomyces griseus.	1.98	1	antibiotic fungicide; cyclic ketone; dicarboximide; piperidine antibiotic; piperidones; secondary alcohol	anticoronaviral agent; bacterial metabolite; ferroptosis inhibitor; neuroprotective agent; protein synthesis inhibitor
dinitrofluorobenzene Dinitrofluorobenzene: Irritants and reagents for labeling terminal amino acid groups.. 1-fluoro-2,4-dinitrobenzene : The organofluorine compound that is benzene with a fluoro substituent at the 1-position and two nitro substituents in the 2- and 4-positions.	2.02	1	C-nitro compound; organofluorine compound	agrochemical; allergen; chromatographic reagent; EC 2.7.3.2 (creatine kinase) inhibitor; protein-sequencing agent; spectrophotometric reagent
citrulline citrulline : The parent compound of the citrulline class consisting of ornithine having a carbamoyl group at the N(5)-position.	1.99	1	amino acid zwitterion; citrulline	Daphnia magna metabolite; EC 1.14.13.39 (nitric oxide synthase) inhibitor; Escherichia coli metabolite; human metabolite; micronutrient; mouse metabolite; nutraceutical; plant metabolite; protective agent; Saccharomyces cerevisiae metabolite
glycerylphosphorylcholine Glycerylphosphorylcholine: A component of PHOSPHATIDYLCHOLINES or LECITHINS, in which the two hydroxy groups of GLYCEROL are esterified with fatty acids. (From Stedman, 26th ed)	1.99	1	glycerophosphocholine
etoposide [no description available]	2.11	1	beta-D-glucoside; furonaphthodioxole; organic heterotetracyclic compound	antineoplastic agent; DNA synthesis inhibitor
web 2086 WEB 2086: structure given in first source; PAF antagonist	2.11	1	organonitrogen heterocyclic compound; organosulfur heterocyclic compound
triazoles Triazoles: Heterocyclic compounds containing a five-membered ring with two carbon atoms and three nitrogen atoms with the molecular formula C2H3N3.. triazoles : An azole in which the five-membered heterocyclic aromatic skeleton contains three N atoms and two C atoms.	2.92	4	1,2,3-triazole
1-hexadecyl-2-acetyl-glycero-3-phosphocholine Platelet Activating Factor: A phospholipid derivative formed by PLATELETS; BASOPHILS; NEUTROPHILS; MONOCYTES; and MACROPHAGES. It is a potent platelet aggregating agent and inducer of systemic anaphylactic symptoms, including HYPOTENSION; THROMBOCYTOPENIA; NEUTROPENIA; and BRONCHOCONSTRICTION.. 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine : A 2-acetyl-1-alkyl-sn-glycero-3-phosphocholine betaine which has hexadecyl as the alkyl group. PAF is a potent phospholipid activator and mediator of many leukocyte functions, including platelet aggregation, inflammation, and anaphylaxis.	4.27	18	2-acetyl-1-alkyl-sn-glycero-3-phosphocholine	antihypertensive agent; beta-adrenergic antagonist; bronchoconstrictor agent; hematologic agent; vasodilator agent
omega-n-methylarginine omega-N-Methylarginine: A competitive inhibitor of nitric oxide synthetase.. N(omega)-methyl-L-arginine : A L-arginine derivative with a N(omega)-methyl substituent.	1.99	1	amino acid zwitterion; arginine derivative; guanidines; L-arginine derivative; non-proteinogenic L-alpha-amino acid
palmitoyl-palmityl-lecithin ether palmitoyl-palmityl-lecithin ether: inhibitor of phospholipase A2; structure given in second source. 1-hexadecanoyl-2-hexadecyl-sn-glycero-3-phosphocholine : A 1-acyl-2-alkyl-sn-glycero-3-phosphocholine in which the acyl and alkyl groups at positions 1 and 2 are specified as hexadecanoyl and hexadecyl respectively.	1.99	1	1-acyl-2-alkyl-sn-glycero-3-phosphocholine; phosphatidylcholine O-32:0	Papio hamadryas metabolite
bn 50730 BN 50730: platelet activating factor antagonist; structure given in first source	2.68	3
dinoprostone prostaglandin E2 : Prostaglandin F2alpha in which the hydroxy group at position 9 has been oxidised to the corresponding ketone. Prostaglandin E2 is the most common and most biologically potent of mammalian prostaglandins.	2.03	1	prostaglandins E	human metabolite; mouse metabolite; oxytocic
calcimycin Calcimycin: An ionophorous, polyether antibiotic from Streptomyces chartreusensis. It binds and transports CALCIUM and other divalent cations across membranes and uncouples oxidative phosphorylation while inhibiting ATPase of rat liver mitochondria. The substance is used mostly as a biochemical tool to study the role of divalent cations in various biological systems.	2.4	2	benzoxazole
endothelin-1 Endothelin-1: A 21-amino acid peptide produced in a variety of tissues including endothelial and vascular smooth-muscle cells, neurons and astrocytes in the central nervous system, and endometrial cells. It acts as a modulator of vasomotor tone, cell proliferation, and hormone production. (N Eng J Med 1995;333(6):356-63)	1.99	1
phosphatidylcholines Phosphatidylcholines: Derivatives of PHOSPHATIDIC ACIDS in which the phosphoric acid is bound in ester linkage to a CHOLINE moiety.	1.99	1	1,2-diacyl-sn-glycero-3-phosphocholine
1-palmitoyl-2-acetyl-sn-glycero-3-phosphocholine 1-palmitoyl-2-acetyl-sn-glycero-3-phosphocholine: RN given refers to (S)-isomer. 1-palmitoyl-2-acetyl-sn-glycero-3-phosphocholine : A 1,2-diacyl-sn-glycero-3-phosphocholine in which the two acyl substituents at positions 1 and 2 are specified as palmitoyl and acetyl respectively.	1.99	1	1,2-diacyl-sn-glycero-3-phosphocholine	platelet-activating factor receptor agonist
interleukin-8 Interleukin-8: A member of the CXC chemokine family that plays a role in the regulation of the acute inflammatory response. It is secreted by variety of cell types and induces CHEMOTAXIS of NEUTROPHILS and other inflammatory cells.	2.42	2
lipoteichoic acid lipoteichoic acid: lipopolysaccharides with an acyl group anchored to the cell membrane of gram-positive bacteria; functions as an adhesion molecule to facilitate the binding of bacteria to cells, colonization, and invasion; interacts with CD14 to induce NF-κB activation and inflammatory cytokine production; can function as surface antigen; inhibits remineraliztion of artificial lesions and surface-softened enamels;. lipoteichoic acid : A teichoic acid which is covalently bound to a lipid.	2.02	1

Condition	Relationship Strength	Studies
Encephalitis, Polio [description not available]	2.06	1
Poliomyelitis An acute infectious disease of humans, particularly children, caused by any of three serotypes of human poliovirus (POLIOVIRUS). Usually the infection is limited to the gastrointestinal tract and nasopharynx, and is often asymptomatic. The central nervous system, primarily the spinal cord, may be affected, leading to rapidly progressive paralysis, coarse FASCICULATION and hyporeflexia. Motor neurons are primarily affected. Encephalitis may also occur. The virus replicates in the nervous system, and may cause significant neuronal loss, most notably in the spinal cord. A rare related condition, nonpoliovirus poliomyelitis, may result from infections with nonpoliovirus enteroviruses. (From Adams et al., Principles of Neurology, 6th ed, pp764-5)	2.06	1
Congenital Zika Syndrome [description not available]	2.25	1
Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases.	2.25	1
Zika Virus Infection A viral disease transmitted by the bite of AEDES mosquitoes infected with ZIKA VIRUS. Its mild DENGUE-like symptoms include fever, rash, headaches and ARTHRALGIA. The viral infection during pregnancy, in rare cases, is associated with congenital brain and ocular abnormalities, called Congenital Zika Syndrome, including MICROCEPHALY and may also lead to GUILLAIN-BARRE SYNDROME.	2.25	1
Infections, Chlamydia [description not available]	2.59	2
Chlamydia Infections Infections with bacteria of the genus CHLAMYDIA.	2.59	2
Sterility, Female [description not available]	2.21	1
Infertility, Female Diminished or absent ability of a female to achieve conception.	2.21	1
Sensitivity and Specificity Binary classification measures to assess test results. Sensitivity or recall rate is the proportion of true positives. Specificity is the probability of correctly determining the absence of a condition. (From Last, Dictionary of Epidemiology, 2d ed)	2.21	1
Malignant Melanoma [description not available]	2.52	2
Melanoma A malignant neoplasm derived from cells that are capable of forming melanin, which may occur in the skin of any part of the body, in the eye, or, rarely, in the mucous membranes of the genitalia, anus, oral cavity, or other sites. It occurs mostly in adults and may originate de novo or from a pigmented nevus or malignant lentigo. Melanomas frequently metastasize widely, and the regional lymph nodes, liver, lungs, and brain are likely to be involved. The incidence of malignant skin melanomas is rising rapidly in all parts of the world. (Stedman, 25th ed; from Rook et al., Textbook of Dermatology, 4th ed, p2445)	2.52	2
B16 Melanoma [description not available]	2.11	1
Metastase [description not available]	2.11	1
Neoplasm Metastasis The transfer of a neoplasm from one organ or part of the body to another remote from the primary site.	2.11	1
Allodynia [description not available]	2.05	1
Innate Inflammatory Response [description not available]	2.71	3
Inflammation A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function.	2.71	3
Eczema, Atopic [description not available]	2.02	1
Allergy, Drug [description not available]	2.02	1
Delayed Hypersensitivity [description not available]	2.02	1
Infections, Staphylococcal [description not available]	2.02	1
Dermatitis, Atopic A chronic inflammatory genetically determined disease of the skin marked by increased ability to form reagin (IgE), with increased susceptibility to allergic rhinitis and asthma, and hereditary disposition to a lowered threshold for pruritus. It is manifested by lichenification, excoriation, and crusting, mainly on the flexural surfaces of the elbow and knee. In infants it is known as infantile eczema.	2.02	1
Drug Hypersensitivity Immunologically mediated adverse reactions to medicinal substances used legally or illegally.	2.02	1
Staphylococcal Infections Infections with bacteria of the genus STAPHYLOCOCCUS.	2.02	1
Bleb [description not available]	1.99	1
Pemphigoid [description not available]	1.99	1
Pemphigoid, Bullous A chronic and relatively benign subepidermal blistering disease usually of the elderly and without histopathologic acantholysis.	1.99	1

1-o-hexadecyl-2-n-methylcarbamol -sn-glycerol-3-phosphocholine

Description

Cross-References

Synonyms (34)

Protein Targets (5)

Potency Measurements

Bioassays (4)

Research

Studies (22)

Market Indicators

Research Demand Index: 11.42

Study Types